Sabra Health Care REIT (SBRA) Common Equity (2010 - 2026)

Sabra Health Care REIT's Common Equity history runs 17 years deep, the most recent figure standing at $2.8 billion for Q1 2026.

• On a quarterly basis, Common Equity rose 3.1% year-over-year to $2.8 billion in Q1 2026; TTM through Mar 2026 was $2.8 billion, a 3.1% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, up 3.01% from the prior year.
• Common Equity declined to $2.8 billion in Q1 2026 per SBRA's latest filing, from $2.8 billion in the prior quarter.
• Across five years, Common Equity topped out at $3.4 billion in Q1 2022 and bottomed at $2.7 billion in Q1 2025.
• The 5-year median for Common Equity is $2.8 billion (2025), against an average of $2.9 billion.
• Across the five-year window, Common Equity fell 11.46% in 2023 and gained 3.1% in 2026, its largest moves.
• Year by year, Common Equity stood at $3.1 billion in 2022, then decreased by 8.31% to $2.8 billion in 2023, then decreased by 2.19% to $2.7 billion in 2024, then rose by 3.01% to $2.8 billion in 2025, then dropped by 1.34% to $2.8 billion in 2026.
• Per Business Quant, the three latest SBRA Common Equity figures stand at $2.8 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.8 billion (Q3 2025).